Bellevue Group AG

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Bellevue Group AG
CIK #0001674546
CIK Period
0001674546
/
Sector Form 13F Holdings Cap ($BB) Value ($BB)
ISIS Pharmaceuticals Inc 5.4 0.4
Argenx SE 19.8 0.3
Vertex Pharmaceuticals Inc / Ma 70.6 0.3
Neurocrine Biosciences Inc 9.3 0.3
Intuitive Surgical Inc 72.5 0.2
Alnylam Pharmaceuticals Inc 17.2 0.2
Boston Scientific Corp 53.6 0.2
Revolution Medicines Inc 1.3 0.2
Stryker Corp 74.8 0.2
Moderna Inc 56.6 0.2
Oneida Resources Corp 5.2 0.2
Agios Pharmaceuticals Inc 1.2 0.2
Abbott Laboratories 187.3 0.2
Dexcom Inc 29.3 0.1
Incyte Corp 16.8 0.1
Edwards Lifesciences Corp 58.9 0.1
Celldex Therapeutics Inc 1.3 0.1
UnitedHealth Group Inc 477.0 0.1
Insulet Corp 15.7 0.1
Becton Dickinson & Co 69.7 0.1
Medtronic Holdings Ltd 118.5 0.1
Biohaven Ltd 10.3 0.1
Insmed Inc 2.4 0.1
Arvinas Inc 2.3 0.1
Tandem Diabetes Care Inc 3.9 0.1
CareDx Inc 1.2 0.1
Wellpoint Inc 114.1 0.1
Penumbra Inc 4.8 0.1
Exact Sciences Corp 7.2 0.0
Zimmer Holdings Inc 22.3 0.0
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2024
13F-HR [0001674546]
SC 13G [0001674546]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bellevue Group AG Accolade Inc [2023-02-14]
Bellevue Group AG Outset Medical Inc [2023-02-14]
Terms | Privacy | Guide
tony@aum13f.com